Regencell Bioscience Holdings Limited
RGC
Peringkat dalam Saham
#3382
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.41
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$5.16B
Perubahan (1 hari)
3.56%
Perubahan (1 tahun)
-35.07%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Jumlah saham beredar untuk Regencell Bioscience Holdings Limited (RGC)
Jumlah saham beredar per June 2026: 494.70M
Menurut laporan keuangan terbaru dan harga saham Regencell Bioscience Holdings Limited, jumlah saham beredar saat ini adalah 494.70M. Pada akhir June 2024, perusahaan memiliki 494.49M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Regencell Bioscience Holdings Limited (RGC) dari 2019 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 494.70M | 0.04% |
| 2025 | 494.49M | 0.00% |
| 2024 | 494.49M | 0.00% |
| 2023 | 494.49M | 0.00% |
| 2022 | 494.49M | 2.93% |
| 2021 | 480.40M | 0.00% |
| 2020 | 480.40M | 0.00% |
| 2019 | 480.40M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 385.01% |
IN
|
